Search

everythinglearnresearchcommunity

for

Search:↓

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

The new compound may be a safer alternative to finasteride for prostate protection.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

Blocking 11β-HSD1 can lessen the harmful effects of glucocorticoids on hair growth cells.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Researchers found new potential but less potent rat enzyme inhibitors using a 3D model.

Targeting ornithine decarboxylase can help prevent skin cancer.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Patients with the same vitamin D receptor mutation showed different symptoms due to other factors.

A rare genetic mutation causes resistance to vitamin D, leading to severe rickets and requiring high doses of calcium and vitamin D for treatment.

Two types of 5α-reductase are in dog skin, which might make dutasteride better than finasteride for treating dog hair loss.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Finasteride dosages should be adjusted based on CYP3A5 genotype and liver function to avoid side effects.

CYP154C7 enzyme can effectively modify steroids and is promising for commercial use.

5α-reductase 2 is crucial for stress response in male rats.

Enzymes involved in Vitamin A metabolism affect hair growth and type in mice.

The study created a model to help design new inhibitors for steroidal 5α-reductase enzymes.

Farudodstat may effectively treat alopecia areata without harmful side effects.

Finasteride may cause kidney damage.

2-Hydroxy-1,4-naphthoquinone is a strong 5α-reductase inhibitor.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Finasteride poorly inhibits type 1 5AR, affecting its effectiveness.

ODC1 gene mutations cause a neurodevelopmental disorder with large head size, hair loss, and facial abnormalities.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

Reduced androgens linked to kinky hair disorder and hair loss; 5a-reductase inhibitors may help.

People with PCNT mutations often develop severe insulin resistance and early-onset diabetes during childhood or adolescence.